Genmab A (GMAB) Current Taxes (2018 - 2026)
Genmab A (GMAB) posted Current Taxes of -$21.0 million for Q1 2026, down 148.84% on a QoQ basis from $43.0 million in Q4 2025, and up 57.14% year-over-year from -$13.4 million in Q1 2025.
Genmab A (GMAB) Current Taxes (2018 - 2026) Analysis & Trends
Genmab A's Current Taxes history runs 7 years deep, the most recent figure standing at -$21.0 million for Q1 2026.
- Quarterly Current Taxes rose 57.14% year-over-year to -$21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.0 million (up 57.14% YoY) and the FY2025 annual result came in at $43.0 million, down 82.01% from the prior year.
- Current Taxes was -$21.0 million for Q1 2026 at Genmab A, down from $43.0 million in the prior quarter.
- Across five years, Current Taxes topped out at $239.0 million in Q4 2024 and bottomed at -$228.0 million in Q3 2024.
- A 4-year average of -$57.9 million and a median of -$53.0 million in 2024 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes surged 2887.5% — and 2025, when it plunged 82.01%.
- Genmab A's Current Taxes stood at $8.0 million in 2023, then jumped by 2887.5% to $239.0 million in 2024, then plunged by 82.01% to $43.0 million in 2025, then plunged by 148.84% to -$21.0 million in 2026.
- Business Quant data shows GMAB's Current Taxes at -$21.0 million in Q1 2026, $43.0 million in Q4 2025, and -$217.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | -21.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.00 Mn |
| Dec 31, 2025 | 43.00 Mn |
| Sep 30, 2025 | -217.00 Mn |
| Jun 30, 2025 | -136.00 Mn |
| Mar 31, 2025 | -49.00 Mn |
| Dec 31, 2024 | 239.00 Mn |
| Sep 30, 2024 | -228.00 Mn |
| Jun 30, 2024 | -161.00 Mn |
| Mar 31, 2024 | -57.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Sep 30, 2020 | 1,226.00 |
| Dec 31, 2019 | 73.00 |
| Sep 30, 2019 | 59.32 Mn |
| Dec 31, 2018 | -51.42 Mn |